Geron Shares Remain Elevated, Up 28.3% With Some Attributing Upside To Johnson & Johnson Job Posting For a Strategic Pricing Manager For Imbruvica & Imetelstat, Drugs Its Partnered On With AbbVie and Geron, Respectively